MedTrace Logo

Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients

NCT02395198 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2467

Last updated 2017-05-31

No results posted yet for this study

Summary

The aim of the present study is to estimate the national annual prevalence and incidence of current hepatitis C virus (HCV) infections among opioid dependent individuals in opioid substitution treatment (OST) based on a representative sample of approximately 2,500 outpatients in 100 substitution facilities across Germany. Furthermore, the study aims to describe factors influencing HCV therapy initiation and seroconversion during OST.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • Janssen-Cilag G.m.b.H

    collaborator INDUSTRY

  • Prof. Dr. med. Jens Reimer

    lead OTHER

Principal Investigators

  • Jens Reimer, Prof. Dr. · University Medical Center Hamburg-Eppendorf, Centre for Interdisciplinary Addiction Research (CIAR), Hamburg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-04-30
Completion
2017-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02395198 on ClinicalTrials.gov